Follow the Ocean Biomedical, Inc. share price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was reported on 6 October 2023 (J). Among the most active insiders: AJJARAPU SURENDRA K. All data is openly available.
7
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Ocean Biomedical, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
1,365,000 sharesClass A Common Stock, par value $0.0001SEC:0001493152-23-005358:0
7 of 7 declarations
About Ocean Biomedical, Inc.
Ocean Biomedical, Inc. is a biotechnology company focused on developing innovative treatments for serious diseases. It is listed on NASDAQ under the ticker OCEA.